Minimum structure requirement of immunomodulatory glycolipids for predominant Th2 cytokine induction and the discovery of non-linear phytosphingosine analogs

被引:32
作者
Toba, Tetsuya
Murata, Kenji
Nakanishi, Kyoko
Takahashi, Bitoku
Takemoto, Naohiro
Akabane, Minako
Nakatsuka, Takashi
Imajo, Seiichi
Yamamura, Takashi
Miyake, Sachiko
Annoura, Hirokazu
机构
[1] Biomedical Research Laboratories, Daiichi Asubio Pharma Co., Ltd
[2] National Institute of Neuroscience, National Center for Neuroscience and Psychiatry
关键词
OCH; Th2; cytokine; non-linear phytosphingosine analogs;
D O I
10.1016/j.bmcl.2007.02.081
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analogs of immunomodulatory glycolipid OCH (2) were prepared and minimum structure requirement to exhibit equivalent profiles was disclosed. Analogs bearing non-linear hydrocarbon chain in the phytosphingosine moiety (18, 19) were shown for the first time to possess comparable cytokine inducing profile to 2. Molecular modeling of 2/hCD1d complex based on the crystal structure of alpha-GalCer (1)/hCDld complex is also described. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2781 / 2784
页数:4
相关论文
共 25 条
[11]   MACROMODEL - AN INTEGRATED SOFTWARE SYSTEM FOR MODELING ORGANIC AND BIOORGANIC MOLECULES USING MOLECULAR MECHANICS [J].
MOHAMADI, F ;
RICHARDS, NGJ ;
GUIDA, WC ;
LISKAMP, R ;
LIPTON, M ;
CAUFIELD, C ;
CHANG, G ;
HENDRICKSON, T ;
STILL, WC .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :440-467
[12]   STRUCTURE-ACTIVITY RELATIONSHIP OF ALPHA-GALACTOSYLCERAMIDES AGAINST B16-BEARING MICE [J].
MORITA, M ;
MOTOKI, K ;
AKIMOTO, K ;
NATORI, T ;
SAKAI, T ;
SAWA, E ;
YAMAJI, K ;
KOEZUKA, Y ;
KOBAYASHI, E ;
FUKUSHIMA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) :2176-2187
[13]   Practical total synthesis of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, the antitumorial and immunostimulatory alpha-galactosylceramide, KRN7000 [J].
Morita, M ;
Sawa, E ;
Yamaji, K ;
Sakai, T ;
Natori, T ;
Koezuka, Y ;
Fukushima, H ;
Akimoto, K .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1996, 60 (02) :288-292
[14]   Total synthesis of an immunosuppressive glycolipid, (2S,3S,4R)-1-O-(α-D-galactosyl)-2-tetracosanoylamino-1,3,4-nonanetriol [J].
Murata, K ;
Toba, T ;
Nakanishi, K ;
Takahashi, B ;
Yamamura, T ;
Miyake, S ;
Annoura, H .
JOURNAL OF ORGANIC CHEMISTRY, 2005, 70 (06) :2398-2401
[15]   The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells [J].
Oki, S ;
Chiba, A ;
Yamamura, T ;
Miyake, S .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) :1631-1640
[16]   The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids [J].
Porcelli, SA ;
Modlin, RL .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :297-329
[17]  
*SCHRO LLC, MACR VER 9 0
[18]  
*SCHROD LLC, MAESTR VER 7 5 112
[19]   CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells [J].
Sidobre, S ;
Kronenberg, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 268 (01) :107-121
[20]   Synthesis of sphingosine relatives, part 20.: Diastereoselective epoxidation of the double bond at C-4 of sphingosines to provide phytosphingosine relatives such as α-galactosylceramide KRN7000 [J].
Takikawa, H ;
Muto, SE ;
Mori, K .
TETRAHEDRON, 1998, 54 (13) :3141-3150